Common Shares Outstanding: The number of class A shares currently held by investors.
TScan Therapeutics, Inc. (TCRX) had Common Shares Outstanding of 56.75M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$2.51M |
|
$-35.71M |
|
-- |
|
$2.51M |
|
$39.56M |
|
$-37.05M |
|
$1.34M |
|
$-35.71M |
|
$-35.71M |
|
$-35.71M |
|
$-35.71M |
|
$-35.71M |
|
$-35.71M |
|
$-37.05M |
|
$-36.28M |
|
129.84M |
|
129.84M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$188.16M |
|
$9.30M |
|
$74.06M |
|
$262.23M |
|
$29.21M |
|
$32.41M |
|
$89.00M |
|
$118.20M |
|
$144.02M |
|
$144.02M |
|
$144.02M |
|
|
Common Shares Outstanding |
56.75M |
| Cash Flow Statement Financials | |
$-103.32M |
|
$94.54M |
|
$-0.41M |
|
$183.72M |
|
$174.54M |
|
$-9.18M |
|
$9.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.44 |
|
-- |
|
-- |
|
0.18 |
|
0.23 |
|
100.00% |
|
-1475.59% |
|
-1475.59% |
|
-- |
|
-1422.14% |
|
-1422.14% |
|
$-107.55M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-24.80% |
|
-24.80% |
|
-13.62% |
|
-20.24% |
|
$2.54 |
|
$-0.83 |
|
$-0.80 |
|